Arteriovenous fistula creation: should US nephrologists get involved? Arif Asif, MD, Baudouin Leclercq, MD, Donna Merrill, Jacques J Bourgoignie, MD, David Roth, MD  American Journal of Kidney Diseases  Volume 42, Issue 6, Pages 1293-1300 (December 2003) DOI: 10.1053/j.ajkd.2003.08.009 Copyright © 2003 National Kidney Foundation, Inc. Terms and Conditions

Fig 1 One- and 2-year AVF (A) primary (unassisted; intervention-free) and (B) secondary (assisted; with interventions) access survival for age groups younger and older than 65 years and (C) primary (unassisted; intervention-free) and (D) secondary (assisted; with interventions) access survival for patients without and with diabetes. Adapted from Konner et al.22 American Journal of Kidney Diseases 2003 42, 1293-1300DOI: (10.1053/j.ajkd.2003.08.009) Copyright © 2003 National Kidney Foundation, Inc. Terms and Conditions